基于肠道菌群探讨中医从脾胃论治代谢相关脂肪性肝病的理论基础
DOI:
作者:
作者单位:

新疆维吾尔自治区中医医院

作者简介:

通讯作者:

中图分类号:

基金项目:

新疆维吾尔自治区自然科学基金项目(No.2022D01C155);自治区卫生健康青年医学科技人才专项科研项目(WJWY-202432);乐德行全国名中医工作室(国中医药办人教函[2022]245号)


To explore the theoretical basis of spleen and stomach treatment of Metabolic associated fatty liver disease based on intestinal flora
Author:
Affiliation:

Traditional Chinese Medicine of Xinjiang Uygur Autonomous Region

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
    摘要:

    肠道菌群失调与代谢相关脂肪性肝病(Metabolic associated fatty liver disease,MAFLD)的关系密切,调节肠道菌群可以改善MAFLD。从脾胃论治乃中医临床肝病经典治疗方法,临床疗效显著,调节肠道菌群成为从脾胃论治MAFLD新的研究途径。笔者从肠道菌群入手阐述中医从脾胃论治MAFLD的机制,为中医从脾胃论治MAFLD提供现代生物学基础。

    Abstract:

    Metabolic associated fatty liver disease (MAFLD) is closely related to intestinal flora disorders, and regulation of intestinal flora can improve MAFLD. Treating MAFLD by spleen and stomach is a classic method of traditional Chinese medicine with remarkable clinical effect. Regulating intestinal flora has become a new research approach for treating MAFLD by spleen and stomach. The author elaborates the mechanism of spleen and stomach treatment of MAFLD from intestinal flora in order to provide a modern biological basis for spleen and stomach treatment of MAFLD.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2024-05-12
  • 最后修改日期:2024-07-10
  • 录用日期:2024-07-15
  • 在线发布日期:
  • 出版日期:

温馨提示

关闭